Get exclusive money-saving offers and guides
Straight to your inbox
By signing up, you agree to the Finder
Privacy & Cookies Policy
and
Terms of Use, Disclaimer & Privacy Policy.
How to buy PharmAust shares
Own PharmAust shares in just a few minutes.
Investments
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
PharmAust Limited is a biotechnology business based in Australia. PharmAust shares (PAA) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. PharmAust has a trailing 12-month revenue of around $3.4 million. If you're looking to buy shares, check out the steps below.
How to buy shares in PharmAust
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for PharmAust . Find the share by name or ticker symbol: PAA. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until PharmAust reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of PharmAust . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
US stocks
Finder Award
Our top pick for
Cheap broker fees
Finder Award
Our top pick for
Long-term investing
Finder Award
PharmAust share price
Use our graph to track the performance of PAA stocks over time.PharmAust shares at a glance
Information last updated 2021-06-17.
| 52-week range | $0.09 - $0.25 |
|---|---|
| 50-day moving average | $0.0957 |
| 200-day moving average | $0.1015 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.007 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy PharmAust stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
PharmAust price performance over time
Historical closes compared with the last close of A$0.1
| 1 week (2021-06-16) | 8.70% |
|---|---|
| 1 month (2021-05-21) | 5.26% |
| 3 months (2021-03-23) | -4.76% |
| 6 months (2020-12-23) | -9.09% |
| 1 year (2020-06-23) | -25.93% |
|---|---|
| 2 years (2019-06-21) | 150.00% |
| 3 years (2018-06-22) | 156.41% |
| 5 years (2016-06-23) | 30.04% |
PharmAust financials
| Revenue TTM | $3.4 million |
|---|---|
| Gross profit TTM | $3.9 million |
| Return on assets TTM | -8.62% |
| Return on equity TTM | -18.29% |
| Profit margin | -49.63% |
| Book value | 0.029 |
| Market capitalisation | $28.8 million |
TTM: trailing 12 months
PharmAust share dividends
We're not expecting PharmAust to pay a dividend over the next 12 months.
Have PharmAust 's shares ever split?
PharmAust 's shares were split on a 1:20 basis on 29 October 2015. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your PharmAust shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for PharmAust shares which in turn could have impacted PharmAust 's share price.
PharmAust share price volatility
Over the last 12 months, PharmAust 's shares have ranged in value from as little as $0.09 up to $0.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while PharmAust 's is 0.7866. This would suggest that PharmAust 's shares are less volatile than average (for this exchange).
PharmAust overview
PharmAust Limited, a clinical-stage company, develops targeted cancer therapeutics for human and animal healthcare. The company develops drug discovery intellectual property for the treatment of various cancers in humans and animals. Its lead candidate is Monepantel, which are in Phase II clinical trials for the treatment of cancer. The company also provides highly specialized medicinal and synthetic chemistry services on a contract basis to clients to the drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia.
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to get $120 off Nintendo Switch on Amazon Prime Day
Amazon Australia is selling the Nintendo Switch video game console for $349 during Prime Day - that's over $120 off the RRP.
-
Amazon Prime Day Australia 2021: All the best deals from Day 2
Here are all the best deals from Amazon Prime Day Australia's second day - including the return of dirt-cheap Nintendo Switch consoles.
-
Amazon Prime Day’s best deals on big-ticket items: Up to 46% off
From Segways to stand-up paddleboards, these are the best Prime Day savings on the most expensive items.
-
Nacon RIG 500 Pro HC Gen 2 review: Super comfortable gaming headphones
The Nacon Rig 500 Pro HC headphones have wide console and PC compatibility, Dolby Atmos licensing and a genuinely comfortable design, even for longer gaming sessions.
-
Oppo Find X3 Neo 5G review: Oppo’s better flagship phone
The Oppo Find X3 Neo lacks the utter flagship features of the Find X3 Pro, but you won't miss them, while you will enjoy its lower price point.
-
7 health insurance deals to save you money at tax time
Avoid the MLS tax and get a rebate by taking out health insurance. Here are 7 deals that’ll save you money on your tax returns.
-
Today’s ASX top stocks: Milton Corporation (MLT ↑16.0%), Oneview Healthcare (ONE ↑12.8%)
The 10 biggest movers on the ASX for Tuesday 22 June 2021.
-
Mobile plans are now more expensive, but here’s a hack to save $200 a year
Telstra, Optus and Vodafone keep raising their prices even as the rest of the market is more affordable than ever.
-
Prime Day VR gaming deal: $60 off the Oculus Quest 2
Amazon is selling the standalone Oculus Quest 2 virtual-reality headset for $432.12. You can also score $77 off the 256GB version.
Ask an Expert
